Literature DB >> 22730529

Epigenetic silencing of CD8 genes by ThPOK-mediated deacetylation during CD4 T cell differentiation.

Jinxiu Rui1, Haifeng Liu, Xiaoyan Zhu, Yu Cui, Xiaolong Liu.   

Abstract

Intrathymic CD4/CD8 differentiation is a process that establishes the mutually exclusive expression profiles of the CD4 and CD8 T cell lineage. The RUNX3-mediated silencing of CD4 in CD8 lineage cells has been well documented; however, it is unclear how CD8 is silenced during CD4 lineage differentiation. In this study, we report that, by directly binding the CD8 locus, ThPOK works as a negative regulator that mediates the deacetylation of Cd8 genes and repositions the CD8 alleles close to heterochromatin during the development of the CD4 lineage. The ectopic expression of ThPOK resulted in increased recruitment of histone deacetylases at Cd8 loci; the enhanced deacetylation of Cd8 genes eventually led to impaired Cd8 transcription. In the absence of ThPOK, the enhanced acetylation and transcription of Cd8 genes were observed. The results of these studies showed that Cd8 loci are the direct targets of ThPOK, and, more importantly, they provide new insights into CD8 silencing during CD4 lineage commitment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22730529     DOI: 10.4049/jimmunol.1201077

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  An Immunotherapeutic CD137 Agonist Releases Eomesodermin from ThPOK Repression in CD4 T Cells.

Authors:  Payal Mittal; Rebecca Abblett; Joseph M Ryan; Adam T Hagymasi; Archibald Agyekum-Yamoah; Julia Svedova; Steven L Reiner; Marie-Clare St Rose; Matthew P Hanley; Anthony T Vella; Adam J Adler
Journal:  J Immunol       Date:  2018-01-05       Impact factor: 5.422

2.  Runt-related transcription factor 3 is involved in the altered phenotype and function in ThPok-deficient invariant natural killer T cells.

Authors:  Xia Liu; Shengxia Yin; Wenqiang Cao; Wei Fan; Lei Yu; Li Yin; Lie Wang; Jianli Wang
Journal:  Cell Mol Immunol       Date:  2014-02-24       Impact factor: 11.530

3.  RAG1-mediated ubiquitylation of histone H3 is required for chromosomal V(D)J recombination.

Authors:  Zimu Deng; Haifeng Liu; Xiaolong Liu
Journal:  Cell Res       Date:  2015-01-09       Impact factor: 25.617

Review 4.  Roles of repressive epigenetic machinery in lineage decision of T cells.

Authors:  Taku Naito; Ichiro Taniuchi
Journal:  Immunology       Date:  2013-06       Impact factor: 7.397

Review 5.  The multifaceted roles of Bcl11b in thymic and peripheral T cells: impact on immune diseases.

Authors:  Dorina Avram; Danielle Califano
Journal:  J Immunol       Date:  2014-09-01       Impact factor: 5.422

Review 6.  Vertebrate GAF/ThPOK: emerging functions in chromatin architecture and transcriptional regulation.

Authors:  Avinash Srivastava; Amitha Sampath Kumar; Rakesh K Mishra
Journal:  Cell Mol Life Sci       Date:  2017-08-30       Impact factor: 9.261

7.  Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair.

Authors:  Avinash Srivastava; Rakesh K Mishra
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

8.  60-kDa Tat-interactive protein (TIP60) positively regulates Th-inducing POK (ThPOK)-mediated repression of eomesodermin in human CD4+ T cells.

Authors:  Yangyang Li; Andy Tsun; Zhimei Gao; Zhijun Han; Yayi Gao; Zhiyuan Li; Fang Lin; Yan Wang; Gang Wei; Zhengju Yao; Bin Li
Journal:  J Biol Chem       Date:  2013-04-22       Impact factor: 5.157

9.  The microRNA biogenesis machinery modulates lineage commitment during αβ T cell development.

Authors:  Levi J Rupp; Brenna L Brady; Andrea C Carpenter; Maria Elena De Obaldia; Avinash Bhandoola; Remy Bosselut; Stefan A Muljo; Craig H Bassing
Journal:  J Immunol       Date:  2014-09-12       Impact factor: 5.422

Review 10.  What Happens in the Thymus Does Not Stay in the Thymus: How T Cells Recycle the CD4+-CD8+ Lineage Commitment Transcriptional Circuitry To Control Their Function.

Authors:  Melanie S Vacchio; Rémy Bosselut
Journal:  J Immunol       Date:  2016-06-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.